http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011031944-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e91c6cc75aae38943f85662e8ac3d1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9e64daffd3b570f114a340e41f0594b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96466 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate | 2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50e3b53afe18910762255962f7550776 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fda11c6f0e86557e521c0cab14357a3 |
publicationDate | 2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2011031944-A1 |
titleOfInvention | Toll-like receptor 4 deficiency and downstream effectors cause pulmonary emphysema |
abstract | The present invention provides compositions and methods for the detection, treatment, and prevention of emphysema/COPD. Compositions of the present invention comprise TLR4 activators, Nox3 inhibitors, and Cathepsin E inhibitors useful in the treatment or prevention of emphysema/COPD. Cathepsin E is a downstream effector of TLR4, wherein when cathepsin E is overexpressed in lung of an individual, the individual is at higher risk of developing emphysema/COPD. Cathepsin E is further identified as a biomarker useful in the identification of an individual with, or at-risk of developing emphysema/COPD. |
priorityDate | 2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1404.